Press and Media

Filter by

30.11.17

Blue Phantom system used for acceptance of the first Varian Halcyon™ machine in Europe

Schwarzenbruck, November 30th, 2017 – IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy solutions and radiation therapy integrated quality assurance (QA) for the treatment of cancer, announces the acceptance and beam model validation of the first Varian Halcyon™ machine in Europe to go clinical, at the hospital UZ Leuven in Belgium, using IBA Dosimetry’s Blue Phantom water phantom system.

Read more
16.11.17

IBA TRADING UPDATE - THIRD QUARTER 2017

PROTON THERAPY AND OTHER ACCELERATORS PROJECTS ON TRACK, DOSIMETRY SALES UP 20%, GUIDANCE REITERATED

Read more
02.11.17

Puebla hospital advances Imaging and Radiation Therapy Quality Assurance (QA) in Mexico using IBA Dosimetry solutions

High-end QA equipment, including Dolphin® transmission detector, position Puebla hospital as a leading healthcare center in Latin America, ensuring safer diagnostic imaging and RT.

Read more
10.10.17

IBA signs global construction collaboration with VINCI

New collaboration to provide dedicated proton therapy center design and construction support for customers

Read more
20.09.17

IBA releases the world’s smallest ionization chamber – The RAZOR Nano Chamber enables more precise stereotactic beam scanning

IBA releases the world’s smallest ionization chamber – The RAZOR Nano Chamber enables more precise stereotactic beam scanning With its beam quality independent characteristic and the spherical shape of its active volume, the RAZOR Nano Chamber is the latest highlight for small field dosimetry at IBA. The waterproof, ventilated small ionization chamber with enhanced long-term stability, an extremely small diameter of 2 mm and a cavity volume of only 0.003 ccm allows measurements of small fields (< 2x2 cm) with a high spatial resolution and low penumbra values.

Read more
24.08.17

IBA Reports Half Year Results for 2017

Louvain-La-Neuve, Belgium, August 24, 2017 - IBA (Ion Beam Applications SA, EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces its consolidated results for the first half of 2017.

Read more
26.07.17

1,000 radiation therapy centers choose myQA®

myQA® has been selected by 1,000 customers around the world as their trusted global QA platform to integrate quality assurance applications, people, and know-how.

Read more
26.06.17

ICC training course « Small Fields and FFF » has been accredited by EBAMP

IBA Dosimetry successfully passed the evaluation for its ICC training course “Small Fields and FFF: The New Regulation DIN 6809-8 in Theory and Hands-on Practice.” This is the first training for which IBA applied for accreditation under the new procedure set by the European Federation of Medical Physics Associations (EFOMP).

Read more
20.06.17

IBA releases the newest version of myQA® Global Platform for Integrated Quality Assurance

The newest release of myQA, enables users to integrate IBA’s Dolphin Transmission Detector measurements into their linac machine QA dosimetry tests. This also provides an easy comparison of results and efficient trend analysis.

Read more
18.05.17

IBA Dolphin® Patient Treatment QA Solution First Clinical Use In Japan

Osaka International Cancer Institute has successfully validated and clinically implemented the Dolphin transmission detector system. With the use of Dolphin, the team opened a new area of QA standard for improved efficiency and treatment quality in radiation therapy. To address the special high demands of SRS and SBRT cases the hospital’s team has clinically implemented Dolphin due to the system’s ability to verify treatment doses in 3D within the patient’s individual anatomy...

Read more
1 / 5